Oral Plasmid DNA Delivery Systems for Genetic Immunisation

References

• Alpar, H.O. and Bramwell, V.W. (2002) “Current status of DNA vaccines and their route of administration”, Crit. Rev. Ther. Drug Carrier Syst. 19, 307–383.
   PubMed Web of Science ®Google Scholar
• Alpar, H.O., Ozsoy, Y., Bowen, J.C., Eyles, J.E., Conway, B.R. and Williamson, E.D. (1996) “Genetic immunisation via mucosal and parenteral routes using microsphere carriers”, Proc. Int. Symp. Control Rel. Bioact. Mater. 23, 861–862.
   Google Scholar
• Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewit, J., De Braekeleer, J., Jongert, E. and Borchard, G. (2003) “Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies”, Int. J. Pharm. 266, 17–27.
   Google Scholar
• Bramwell, V.W., Eyles, J.E., Somavarapu, S. and Alpar, H.O. (2002) “Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen”, Immunology 106, 412–418.
   PubMed Web of Science ®Google Scholar
• Butts, C., Zubkoff, I., Robbins, D.S., Cao, S. and Sarzotti, M. (1998) “DNA immunization of infants: potential and limitations”, Vaccine 16, 1444–1449.
   PubMed Web of Science ®Google Scholar
• Chen, S.C., Jones, D.H., Fynan, E.F., Farrar, G.H., Clegg, J.C., Greenberg, H.B. and Herrmann, J.E. (1998) “Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles”, J. Virol. 72, 5757–5761.
   Web of Science ®Google Scholar
• Chew, J.L., Wolfowicz, C.B., Mao, H.Q., Leong, K.W. and Chua, K.Y. (2003) “Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice”, Vaccine 21, 2720–2729.
   PubMed Web of Science ®Google Scholar
• Davis, H.L., Michel, M.L. and Whalen, R.G. (1993) “DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody”, Hum. Mol. Genet. 2, 1847–1851.
   Google Scholar
• Eyles, J.E., Bramwell, V.W., Williamson, E.D. and Alpar, H.O. (2001) “Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration”, Vaccine 19, 4732-4742. Eyles, J.E., Bramwell, V.W., Singh, J., Williamson, E.D. and Alpar, H.O. (2003) “Stimulation of spleen cells in vitro by nanospheric particles containing antigen”, J. Control Release 86, 25–32.
   Google Scholar
• Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M. and Danielsen, M. (1987) “Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure”, Proc. Natl Acad. Sci. USA 84, 7413–7417.
   PubMed Web of Science ®Google Scholar
• Feltquate, D.M., Heaney, S., Webster, R.G. and Robinson, H.L. (1997) “Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization”, J. Immunol. 158, 2278–2284.
   Web of Science ®Google Scholar
• Feng, N., Burns, J.W., Bracy, L. and Greenberg, H.B. (1994) “Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus”, J. Virol. 68, 7766–7773.
   Web of Science ®Google Scholar
• Fischer, L., Barzu, S., Andreoni, C., Buisson, N., Brun, A. and Audonnet, J.C. (2003) “DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge”, Vaccine 21, 1732–1741.
   PubMed Web of Science ®Google Scholar
• Fomsgaard, A., Nielsen, H.V., Nielsen, C., Johansson, K., Machuca, R., Bruun, L., Hansen, J. and Buus, S. (1998) “Comparisons of DNA- mediated immunization procedures directed against surface glyco- proteins of human immunodeficiency virus type-1 and hepatitis B virus”, Apmis 106, 636–646.
   PubMed Web of Science ®Google Scholar
• Fooks, A.R., Sharpe, S.A., Shallcross, J.A., Clegg, J.C. and Cranage, M.P. (2000) “Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein”, Dev. Biol. (Basel) 104, 65–71.
   PubMedGoogle Scholar
• Gao, X. and Huang, L. (1991) “A novel cationic liposome reagent for efficient transfection of mammalian cells”, Biochem. Biophys. Res. Commun. 179, 280–285.
   PubMed Web of Science ®Google Scholar
• Gerdts, V., Babiuk, L.A., van Drunen Littel-van den, H. and Griebel, P.J. (2000) “Fetal immunization by a DNA vaccine delivered into the oral cavity”, Nat. Med. 6, 929–932.
   Google Scholar
• Gerdts, V., Snider, M., Brownlie, R., Babiuk, L.A. and Griebel, P.J. (2002) “Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate”, J. Immunol. 168, 1877-1885. Gregoriadis, G., Saffie, R. and de Souza, J.B. (1997) “Liposome- mediated DNA vaccination”, FEBS Lett. 402, 107–110.
   Google Scholar
• Herrmann, J.E., Chen, S.C., Jones, D.H., Tinsley-Bown, A., Fynan, E.F., Greenberg, H.B. and Farrar, G.H. (1999) “Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles”, Virology 259, 148–153.
   PubMed Web of Science ®Google Scholar
• Jones, B.D., Ghori, N. and Falkow, S. (1994) “Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer’s patches”, J. Exp. Med. 180, 15–23.
   PubMed Web of Science ®Google Scholar
• Jones, D.H., Corris, S., McDonald, S., Clegg, J.C. and Farrar, G.H. (1997) “Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration”, Vaccine 15, 814–817.
   PubMed Web of Science ®Google Scholar
• Kaneko, H., Bednarek, I., Wierzbicki, A., Kiszka, I., Dmochowski, M., Wasik, T.J., Kaneko, Y. and Kozbor, D. (2000) “Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein”, Virology 267, 8–16.
   PubMed Web of Science ®Google Scholar
• Kirby, C. and Gregoriadis, G. (1984) “Dehydration-Rehydration vesicles—a simple method for high-yield drug entrapment in liposomes”, Bio-Technology 2, 979–984.
   Web of Science ®Google Scholar
• Li, A.F. and Escher, A. (2003) “Intradermal or oral delivery of GAD- encoding genetic vaccines suppresses type 1 diabetes”, DNA Cell. Biol. 22, 227–232.
   Google Scholar
• Li, J., Huang, Y., Liang, X., Lu, M., Li, L., Yu, L. and Deng, R. (2003) “Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy”, Virus Res. 98, 63–74.
   PubMed Web of Science ®Google Scholar
• Lundholm, P., Asakura, Y., Hinkula, J., Lucht, E. and Wahren, B. (1999) “Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA”, Vaccine 17, 2036–2042.
   PubMed Web of Science ®Google Scholar
• McCluskie, M.J., Brazolot Millan, C.L., Gramzinski, R.A., Robinson, H.L., Santoro, J.C., Fuller, J.T., Widera, G., Haynes, J.R., Purcell, R.H. and Davis, H.L. (1999) “Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates”, Mol. Med. 5, 287–300.
   Web of Science ®Google Scholar
• McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. (1992) “The mucosal immune system: from fundamental concepts to vaccine development”, Vaccine 10, 75–88.
   PubMed Web of Science ®Google Scholar
• Mittal, S.K., Aggarwal, N., Sailaja, G., van Olphen, A., HogenEsch, H., North, A., Hays, J. and Moffatt, S. (2000) “Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response”, Vaccine 19, 253–263.
   PubMed Web of Science ®Google Scholar
• Mulholland, K. (1998) “Serious infections in young infants in developing countries”, Vaccine 16, 1360–1362.
   PubMed Web of Science ®Google Scholar
• Perrie, Y., Obrenovic, M., McCarthy, D. and Gregoriadis, G. (2002) “Liposome (Lipodine)-mediated DNA vaccination by the oral route”, J. Liposome Res. 12, 185–197.
   PubMed Web of Science ®Google Scholar
• Roy, K., Mao, H.Q., Huang, S.K. and Leong, K.W. (1999) “Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy”, Nat. Med. 5, 387–391.
   Web of Science ®Google Scholar
• Salazar, M., Deulofeut, H., Granja, C., Deulofeut, R., Yunis, D.E., Marcus-Bagley, D., Awdeh, Z., Alper, C.A. and Yunis, E.J. (1995) “Normal HBsAg presentation and T-cell defect in the immune response of nonresponders”, Immunogenetics 41, 366–374.
   PubMed Web of Science ®Google Scholar
• Shaw, D.M., Gaerthe, B., Leer, R.J., Van Der Stap, J.G., Smittenaar, C., Heijne Den Bak-Glashouwer, M., Thole, J.E., Tielen, F.J., Pouwels, P.H. and Havenith, C.E. (2000) “Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli”, Immunology 100, 510–518.
   Google Scholar
• Simberg, D., Hirsch-Lerner, D., Nissim, R. and Barenholz, Y. (2000) “Comparison of different commercially available cationic lipid- based transfection kits”, J. Liposome Res. 10, 1–13.
   Web of Science ®Google Scholar
• Sizemore, D.R., Branstrom, A.A. and Sadoff, J.C. (1995) “Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immuniza- tion”, Science 270, 299–302.
   PubMed Web of Science ®Google Scholar
• Stewart, M.J., Plautz, G.E., Del Buono, L., Yang, Z.Y., Xu, L., Gao, X., Huang, L., Nabel, E.G. and Nabel, G.J. (1992) “Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice”, Hum. Gene Ther. 3, 267–275.
   Web of Science ®Google Scholar
• Stribling, R., Brunette, E., Liggitt, D., Gaensler, K. and Debs, R. (1992) “Aerosol gene delivery in vivo”, Proc. Natl Acad. Sci. USA 89, 11277–11281.
   PubMed Web of Science ®Google Scholar
• Weijer, C. (2000) “The future of research into rotavirus vaccine”, BMJ 321, 525–526.
   PubMed Web of Science ®Google Scholar
• Wierzbicki, A., Kiszka, I., Kaneko, H., Kmieciak, D., Wasik, T.J., Gzyl, J., Kaneko, Y. and Kozbor, D. (2002) “Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein”, Vaccine 20, 1295–1307.
   PubMed Web of Science ®Google Scholar
• Wright, P.F. (1998) “Infectious diseases in early life in industrialized countries”, Vaccine 16, 1355–1359.
   PubMed Web of Science ®Google Scholar
• Xiang, R., Lode, H.N., Chao, T.H., Ruehlmann, J.M., Dolman, C.S., Rodriguez, F., Whitton, J.L., Overwijk, W.W., Restifo, N.P. and Reisfeld, R.A. (2000) “An autologous oral DNA vaccine protects against murine melanoma”, Proc. Natl Acad. Sci. USA 97, 5492–5497.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Silvestri, N., Whitton, J.L. and Hassett, D.E. (2002) “Neonates mount robust and protective adult-like CD8(þ)-T-cell responses to DNA vaccines”, J. Virol. 76, 11911–11919.
   Web of Science ®Google Scholar